Gabapentin Capsule
Product Images NDC 50090-7169

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7169). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

A mathematical formula describing creatinine clearance (CLCr) calculation, which includes variables for age (years), weight (kg), and serum creatinine (mg/dL), with a multiplier adjustment for female patients.*

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

A line graph comparing mean pain scores over an 8-week period between a placebo group and a group receiving 3600 mg/day of Gabapentin. The x-axis represents weeks (Baseline to 8), and the y-axis represents mean pain scores from 0 to 10. The graph is divided into a 4-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Line graph showing mean pain scores over 7 weeks in a study with three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents time in weeks, and the y-axis shows mean pain scores from 0 to 10. The graph indicates a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) dosages in two studies. Study 1 shows 12% response for placebo and 29% for 3600 mg gabapentin. Study 2 shows 14% for placebo, 32% for 1800 mg gabapentin, and 34% for 2400 mg gabapentin. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

A scatter plot chart comparing percentage difference (%) on the y-axis and daily dose (mg) on the x-axis for Gabapentin. The chart shows data points from three studies labeled a, b, and c represented by different symbols and shades. Daily doses range from around 600 mg to 1800 mg, with percentage differences ranging from about 7% to 18%.*

FDA Label Image

Label Image (Lbl500907169)

Label for Gabapentin 100 mg capsules by A-S Medication Solutions. The label shows the product name, strength (100 mg), dosage form (capsule), quantity (90 capsules), storage instructions (68 to 77 degrees F), and labeler information in Libertyville, IL. It includes the NDC 50090-7169-0 and a lot number S5734-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.